NOVARTIS N (NOT DU) stock market data APIs
€120.3657
0.14(0.1%)
as of September 15, 2026
Try our APIs with
free plan!
NOVARTIS N Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NOT.DU.
Prev. Close
120.3657
Open
120.7887
High
121.7957
Low
120.3619
52 wk Range
100.0226-140.68
Market Cap
160 075 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NOVARTIS N data using free add-ons & libraries
Get NOVARTIS N Fundamental Data
NOVARTIS N Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NOVARTIS N News
New
Changes in the Suominen Leadership Team
Suominen Corporation Suominen Corporation's stock exchange release on September 16, 2026 at 6:30 p.m. (EEST) Changes in the Suominen Leadership Team As we continue to transform Suominen and strengt...
Novartis Suffers Another Setback After Two High-Profile Surprises Hammered Shares
Novartis added another failure to its docket Wednesday, dropping an experimental treatment for the muscle-wasting disease. Continue Reading
Changes to Suominen Corporation’s share-based incentive plans for management and key employees and to the President & CEO’s share-based signing bonus and annual share reward
Suominen Corporation Suominen Corporation's stock exchange release, September 16, 2026 at 17:00 (EEST) Changes to Suominen Corporation's share-based incentive plans for management and key employees ...
Sironax Announces Option Exercise and Asset Purchase
Sironax USA, Inc. Novartis exercises option to acquire Sironax's brain delivery platform Sironax to advance three clinical-stage programs and multiple early-stage candidates using purchase proceeds ...
Get NOVARTIS N fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
